drugset / Trial / NCT01330563

Drug-drug Interaction Study (CKD-501, Ketoconazole)

NCT01330563

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the effect of Ketoconazole on the pharmacokinetic characteristics of CKD-501 in healthy subject.

Timeline

Start
2011-03
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 200 mg Oral
Subject Lobeglitazone Small molecule 0.5 mg Oral